Showing results (71-80 of 276) with videos related to
Sort By:
Pageof 28
International Journal of Palliative Nursing|August 24, 2006
Palliative treatments for patients with inoperable gastroesophageal cancersSanjay Popat, Juanita Lopez, Sam Chan, et al.Nature Medicine|April 15, 2003
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumorsToshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, et al.The Journal of Pathology|October 26, 2012
Whole-genome methylation analysis of benign and malignant colorectal tumoursAndrew D Beggs, Angela Jones, Mona El-Bahrawy, et al.European Journal of Human Genetics : EJHG|March 11, 2010
Italian appeal court: a genetic predisposition to commit murder?Francesca Forzano, Pascal Borry, Anne Cambon-Thomsen, et al.Lung Cancer (Amsterdam, Netherlands)|May 11, 2020
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?Sanjay Popat, Christian Grohé, Jesus Corral, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2017
Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center ExperienceNadza Tokaca, Sarah Barth, Mary O'Brien, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survivalBhawna Sirohi, Sue Ashley, Alison Norton, et al.Medical Oncology (Northwood, London, England)|December 29, 2011
Chemotherapy-induced bowel obstruction in small cell lung cancer: a case reportJermaine I G Coward, Nicola-Louise Ding, Roger Feakins, et al.Clinical Epidemiology|July 22, 2025
Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in EnglandEseosa Grace Igbinosa, Bodini Dharmasekara, Jennifer K Quint, et al.Future Oncology (London, England)|December 6, 2014
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysisSanjay Popat, Anders Mellemgaard, Kyle Fahrbach, et al.Pageof 28